Position in RIGL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$23,146,756
+$5,126,597 QoQ
Shares Held
591,686
-11.2% QoQ
Ownership
3.17%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#8
of 155 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $730,930,536 across 167 Biotechnology names. RIGL ranks #4 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,664,999 | $188,744,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,440 | $98,170,137 | |
| 3 | IMCR |
Immunocore Holdings plc
|
1,209,894 | $38,414,134 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
This page
|
591,686 | $23,146,756 | |
| 5 | EXEL |
Exelixis, Inc.
|
421,444 | $22,930,768 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
42,122 | $20,923,261 | |
| 7 | TBPH |
Theravance Biopharma, Inc.
|
1,174,910 | $19,973,470 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
2,010,645 | $19,684,214 |
All Filings in RIGL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,146,756 | 591,686 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,020,159 | 666,426 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $21,141,059 | 493,604 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $19,426,390 | 685,718 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,668,864 | 623,004 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $10,165,159 | 565,045 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $6,330,476 | 376,366 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,824,400 | 421,780 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,522,134 | 550,138 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $8,088,470 | 5,465,183 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $6,701,557 | 4,621,764 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,033,599 | 4,660,740 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,910,150 | 4,581,512 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $4,915,103 | 3,723,563 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,312,251 | 3,541,501 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,586,395 | 2,191,861 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,506,648 | 2,218,273 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $2,430,251 | 812,793 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $1,551,230 | 585,370 | Shares | Defined | 2022-02-10 | |
| 2020-12-31 | $593,722 | 169,635 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $2,895,194 | 1,206,331 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $2,582,228 | 1,411,054 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $2,049,109 | 1,313,532 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||